AzurRx BioPharma, Inc. is on the Cruelty Free Investing use of animals list because they exploit animals for product testing.
Some news items:
An article in Globe Newswire cites that, “The company conducted trials on animals and humans to demonstrate an appropriate profile to compensate the pancreatic lipase (enzyme) deficiency that is common with CP patients”. Read full article.
AzurRx BioPharma is a development stage biopharmaceutical company focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions.